Orion's sales up 10% in 2010
This article was originally published in Scrip
Executive Summary
Orion of Finland reported a 10% increase in net sales for 2010 to €850 million, including products arising from its own research such as Stalevo for Parkinson's disease, Simdax for heart failure, the Easyhaler (salbutamol) pulmonary drug and Precedex (dexmedetomidine), an intensive care sedative.